<DOC>
	<DOCNO>NCT02314273</DOCNO>
	<brief_summary>The goal clinical research study find rhIL-11（Interleukin 11） may increase platelet count Childhood patient acute lymphocytic leukemia ( ALL ) develop low platelet count receive standard CAT（cyclophosphamide+Cytosine arabinoside+mercaptopurine，7d） therapy .</brief_summary>
	<brief_title>Effect rhIL-11 Patients With Thrombocytopenia Childhood ALL</brief_title>
	<detailed_description>Group A：patients receive rhIL-11 ( 50 mcg/kg，subcutaneously ) standard chemotherapy，once day 10 day platelet count ≥80,000/mL Group B：control group</detailed_description>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Pancytopenia</mesh_term>
	<mesh_term>Oprelvekin</mesh_term>
	<criteria>new diagnosis ALL TBIL≤34umol/L，Cr≤120umol/L，a normal EF age ＜18 year patient uncontrolled infection patient Acute congestive heart failure chronicity cardiorespiratory functional defect serious cardiac arrhythmia</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>